INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

PHASE2CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

July 31, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

INCB028050

4 mg capsules QD

DRUG

INCB028050

7 mg capsules QD

DRUG

INCB028050

10 mg capsule QD

DRUG

Placebo

Placebo matching INCB028050 QD

Trial Locations (49)

Unknown

Birmingham

Paradise Valley

Peoria

Phoenix

Palm Desert

Santa Maria

Santa Monica

Westlake Village

Whittier

Denver

Aventura

Daytona Beach

Gainesville

Lake Mary

Naples

Palm Harbor

Sarasota

Springfield

South Bend

Wichita

Lexington

Frederick

Wheaton

St Louis

Lincoln

Reno

Freehold

Lake Success

Syracuse

Charlotte

Hickory

Middleburg Heights

Toledo

Tulsa

Duncansville

Pittsburgh

Sellersville

Houston

San Antonio

Arlington

Spokane

Brno

Chomutov

Česká Lípa

Hlučín

Hustopeče

Kroměříž

Prague

Zlín

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY